A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.
(Q40549569)
scientific article published on 2 June 2004
scientific article published on 2 June 2004
Language:
Current Data About
A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.
other details
description | scientific article published on 2 June 2004 |
External Links
(P356) |
10.1074/JBC.M402290200
|
(P698) |
15175350
|